genetic diseases

Pharma

Arrowhead strikes true with first FDA approval

Complicating things is the fact that Arrowhead’s first marketed product will now compete directly with the inaugural launch from its legal foe, Ionis.

Fraiser Kansteiner Nov 18, 2025 3:44pm

FDA approves Soleno's Vykat XR for insatiable hunger disorder

Mar 27, 2025 11:24am

Tryngolza's FDA approval marks 'pivotal moment' for Ionis: CEO

Dec 20, 2024 8:32am

Alnylam Family Health History Road Trip Bernice Bennett

Alnylam embarks on campaign to drive hATTR amyloidosis diagnoses

Mar 13, 2024 10:30am

Pharming scores FDA nod for rare disease drug Joenja

Mar 27, 2023 11:06am